Treatment trials and their design
Langman, M.J.
Clinics in Gastroenterology 7(3): 583-594
1978
ISSN/ISBN: 0300-5089 PMID: 361303 Document Number: 138123
Document emailed within 1 workday
Related Documents
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Lusher, J.M. 1984: Assessment of response to treatment and design of clinical trials Progress in Clinical and Biological Research 150: 167-179
Li, Y.-s. 2010: To modify the design of preclinical trials: a lesson from the failure of neuroprotection trials in stroke Zhonghua Nei Ke Za Zhi 49(9): 733-734
Ribaudo, H.J.; Kuritzkes, D.R.; Schackman, B.R.; Acosta, E.P.; Shikuma, C.M.; Gulick, R.M. 2006: Design issues in initial HIV-treatment trials: focus on ACTG A5095 Antiviral Therapy 11(6): 751-760
Veldhuyzen van Zanten, S.J.; Cleary, C.; Talley, N.J.; Peterson, T.C.; Nyrén, O.; Bradley, L.A.; Verlinden, M.; Tytgat, G.N. 1996: Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials American Journal of Gastroenterology 91(4): 660-673
Guilhot, F.; Guerci, A.; Fiere, D.; Harousseau, J.L.; Maloisel, F.; Bouabdallah, R.; Guyotat, D.; Rochant, H.; Najman, A.; Nicolini, F.; Colombat, P.; Abgrall, J.F.; Ifrah, N.; Brière, J.; Bauters, F.; Navarro, M.; Morice, P.; Bordessoule, D.; Vilque, J.P.; Desablens, B.; Tertian, G.; Blanc, M.; Chastang, C.; Tanzer, J. 1996: The treatment of chronic myelogenous leukemia by interferon and cytosine-arabinoside: rational and design of the French trials. French CML Study Group Bone Marrow Transplantation 17(Suppl 3): S29-S31
Overall, J.E. 1989: Design issues in clinical trials Progress in Clinical and Biological Research 317: 1291-1299
Antczak-Bouckoms, A.; Chalmers, T.C. 1988: The importance of design and analysis in clinical trials Journal of Oral Implantology 14(1): 36-42
Prasad, V.K. 2019: Improving the design of pivotal clinical trials Clinical Advances in Hematology and Oncology: H&o 17(3): 150-152
Fleming, T.R.; Richardson, B.A. 2004: Some design issues in trials of microbicides for the prevention of HIV infection Journal of Infectious Diseases 190(4): 666-674
Gehan, E.A. 1982: Design of controlled clinical trials: use of historical controls Cancer Treatment Reports 66(5): 1089-1093
Neidert, G.L. 1982: Design and interpretation of clinical trials of long-acting analgesics PharmacoTherapy 2(5): 285-286
Dellinger, E.P. 1991: Design and evaluation of clinical trials of antimicrobial agents in surgery Surgery Gynecology and Obstetrics 172 Suppl: 65-72
Pellock, J.M. 1998: Pediatric trials: practical issues. Special populations and trial design Advances in Neurology 76: 167-171
Lee, Y.J.; Wesley, R.A. 1981: Statistical contributions to phase Ii trials in cancer: interpretation, analysis and design Seminars in Oncology 8(4): 403-416
Zhao, Y.-m. 2010: Targets and principles for system design of quality control in clinical trials Zhonghua Yi Xue Za Zhi 90(26): 1801-1803
Fleming, T.R. 1999: Issues in the design of clinical trials: insights from the trastuzumab (Herceptin) experience Seminars in Oncology 26(4 Suppl. 12): 102-107
Black, B. 1990: Design and development of a contoured ossicular replacement prosthesis: clinical trials of 125 cases American Journal of Otology 11(2): 85-89
Wang, R.; Goyal, R.; Lei, Q.; Essex, M.; De Gruttola, V. 2014: Sample size considerations in the design of cluster randomized trials of combination HIV prevention Clinical Trials 11(3): 309-318